Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2010

Open Access 01-12-2010 | Research article

Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis

Authors: Robert M Bennett, Jon Russell, Joseph C Cappelleri, Andrew G Bushmakin, Gergana Zlateva, Alesia Sadosky

Published in: BMC Musculoskeletal Disorders | Issue 1/2010

Login to get access

Abstract

Background

The purpose of this study was to determine whether some of the clinical features of fibromyalgia (FM) that patients would like to see improved aggregate into definable clusters.

Methods

Seven hundred and eighty-eight patients with clinically confirmed FM and baseline pain ≥40 mm on a 100 mm visual analogue scale ranked 5 FM clinical features that the subjects would most like to see improved after treatment (one for each priority quintile) from a list of 20 developed during focus groups. For each subject, clinical features were transformed into vectors with rankings assigned values 1-5 (lowest to highest ranking). Logistic analysis was used to create a distance matrix and hierarchical cluster analysis was applied to identify cluster structure. The frequency of cluster selection was determined, and cluster importance was ranked using cluster scores derived from rankings of the clinical features. Multidimensional scaling was used to visualize and conceptualize cluster relationships.

Results

Six clinical features clusters were identified and named based on their key characteristics. In order of selection frequency, the clusters were Pain (90%; 4 clinical features), Fatigue (89%; 4 clinical features), Domestic (42%; 4 clinical features), Impairment (29%; 3 functions), Affective (21%; 3 clinical features), and Social (9%; 2 functional). The "Pain Cluster" was ranked of greatest importance by 54% of subjects, followed by Fatigue, which was given the highest ranking by 28% of subjects. Multidimensional scaling mapped these clusters to two dimensions: Status (bounded by Physical and Emotional domains), and Setting (bounded by Individual and Group interactions).

Conclusion

Common clinical features of FM could be grouped into 6 clusters (Pain, Fatigue, Domestic, Impairment, Affective, and Social) based on patient perception of relevance to treatment. Furthermore, these 6 clusters could be charted in the 2 dimensions of Status and Setting, thus providing a unique perspective for interpretation of FM symptomatology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33 (2): 160-172. 10.1002/art.1780330203.CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33 (2): 160-172. 10.1002/art.1780330203.CrossRefPubMed
2.
go back to reference Bennett RM: Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clinic Proc. 1999, 74: 385-398. 10.4065/74.4.385.CrossRef Bennett RM: Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clinic Proc. 1999, 74: 385-398. 10.4065/74.4.385.CrossRef
3.
go back to reference Staud R: Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep. 2002, 4: 299-305. 10.1007/s11926-002-0038-5.CrossRefPubMed Staud R: Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep. 2002, 4: 299-305. 10.1007/s11926-002-0038-5.CrossRefPubMed
4.
go back to reference White KP, Speechley M, Harth M, Ostbye T: Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario. The London Fibromyalgia Epidemiology Study. Arthritis Rheum. 1999, 42 (1): 76-83. 10.1002/1529-0131(199901)42:1<76::AID-ANR10>3.0.CO;2-G.CrossRefPubMed White KP, Speechley M, Harth M, Ostbye T: Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario. The London Fibromyalgia Epidemiology Study. Arthritis Rheum. 1999, 42 (1): 76-83. 10.1002/1529-0131(199901)42:1<76::AID-ANR10>3.0.CO;2-G.CrossRefPubMed
5.
go back to reference Verbunt JA, Pernot DH, Smeets RJ: Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes. 2008, 6: 8-10.1186/1477-7525-6-8.CrossRefPubMedPubMedCentral Verbunt JA, Pernot DH, Smeets RJ: Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes. 2008, 6: 8-10.1186/1477-7525-6-8.CrossRefPubMedPubMedCentral
6.
go back to reference Berger A, Dukes E, Martin S, Edelsberg J, Oster G: Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007, 61 (9): 1498-1508. 10.1111/j.1742-1241.2007.01480.x.CrossRefPubMedPubMedCentral Berger A, Dukes E, Martin S, Edelsberg J, Oster G: Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007, 61 (9): 1498-1508. 10.1111/j.1742-1241.2007.01480.x.CrossRefPubMedPubMedCentral
7.
go back to reference Hoffman DL, Dukes E: The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008, 62 (1): 115-126. 10.1111/j.1742-1241.2007.01638.x.CrossRefPubMedPubMedCentral Hoffman DL, Dukes E: The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008, 62 (1): 115-126. 10.1111/j.1742-1241.2007.01638.x.CrossRefPubMedPubMedCentral
8.
go back to reference White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL: Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008, 50 (1): 13-24. 10.1097/JOM.0b013e31815cff4b.CrossRefPubMed White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL: Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008, 50 (1): 13-24. 10.1097/JOM.0b013e31815cff4b.CrossRefPubMed
9.
go back to reference Bennett RM, Jones J, Turk DC, Matallana L: An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007, 8: 27-10.1186/1471-2474-8-27.CrossRefPubMedPubMedCentral Bennett RM, Jones J, Turk DC, Matallana L: An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007, 8: 27-10.1186/1471-2474-8-27.CrossRefPubMedPubMedCentral
10.
go back to reference Barsevick AM: The elusive concept of the symptom cluster. Oncol Nurs Forum. 2007, 34 (5): 971-980. 10.1188/07.ONF.971-980.CrossRefPubMed Barsevick AM: The elusive concept of the symptom cluster. Oncol Nurs Forum. 2007, 34 (5): 971-980. 10.1188/07.ONF.971-980.CrossRefPubMed
11.
go back to reference Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN: Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage. 2006, 31 (1): 85-95. 10.1016/j.jpainsymman.2005.05.015.CrossRefPubMed Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN: Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage. 2006, 31 (1): 85-95. 10.1016/j.jpainsymman.2005.05.015.CrossRefPubMed
12.
go back to reference Ryan CJ, DeVon HA, Horne R, King KB, Milner K, Moser DK, Quinn JR, Rosenfeld A, Hwang SY, Zerwic JJ: Symptom clusters in acute myocardial infarction: a secondary data analysis. Nurs Res. 2007, 56 (2): 72-81. 10.1097/01.NNR.0000263968.01254.d6.CrossRefPubMed Ryan CJ, DeVon HA, Horne R, King KB, Milner K, Moser DK, Quinn JR, Rosenfeld A, Hwang SY, Zerwic JJ: Symptom clusters in acute myocardial infarction: a secondary data analysis. Nurs Res. 2007, 56 (2): 72-81. 10.1097/01.NNR.0000263968.01254.d6.CrossRefPubMed
13.
go back to reference Hall SA, Cinar A, L LC, Kopp ZS, Roehrborn CG, Kaplan SA, Rosen RC: Do urological symptoms cluster among women? Results from the Boston Area Community Health Survey. BJU Int. 2008, 101 (10): 1257-1266. 10.1111/j.1464-410X.2008.07557.x.CrossRefPubMed Hall SA, Cinar A, L LC, Kopp ZS, Roehrborn CG, Kaplan SA, Rosen RC: Do urological symptoms cluster among women? Results from the Boston Area Community Health Survey. BJU Int. 2008, 101 (10): 1257-1266. 10.1111/j.1464-410X.2008.07557.x.CrossRefPubMed
14.
go back to reference Thong MS, van Dijk S, Noordzij M, Boeschoten EW, Krediet RT, Dekker FW, Kaptein AA, for the NECOSAD Study Group: Symptom clusters in incident dialysis patients: associations with clinical variables and quality of life. Nephrol Dial Transplant. 2008, 24 (1): 225-230. 10.1093/ndt/gfn449.CrossRefPubMed Thong MS, van Dijk S, Noordzij M, Boeschoten EW, Krediet RT, Dekker FW, Kaptein AA, for the NECOSAD Study Group: Symptom clusters in incident dialysis patients: associations with clinical variables and quality of life. Nephrol Dial Transplant. 2008, 24 (1): 225-230. 10.1093/ndt/gfn449.CrossRefPubMed
15.
go back to reference Hurtig IM, Raak RI, Kendall SA, Gerdle B, Wahren LK: Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups. Clin J Pain. 2001, 17 (4): 316-322. 10.1097/00002508-200112000-00005.CrossRefPubMed Hurtig IM, Raak RI, Kendall SA, Gerdle B, Wahren LK: Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups. Clin J Pain. 2001, 17 (4): 316-322. 10.1097/00002508-200112000-00005.CrossRefPubMed
16.
go back to reference Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, Gracely RH, Clauw DJ: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003, 48 (10): 2916-2922. 10.1002/art.11272.CrossRefPubMed Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, Gracely RH, Clauw DJ: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003, 48 (10): 2916-2922. 10.1002/art.11272.CrossRefPubMed
17.
go back to reference Hamilton NA, Karoly P, Zautra AJ: Health goal cognition and adjustment in women with fibromyalgia. J Behav Med. 2005, 28 (5): 455-466. 10.1007/s10865-005-9013-8.CrossRefPubMed Hamilton NA, Karoly P, Zautra AJ: Health goal cognition and adjustment in women with fibromyalgia. J Behav Med. 2005, 28 (5): 455-466. 10.1007/s10865-005-9013-8.CrossRefPubMed
18.
go back to reference Thieme K, Turk D: Heterogeneity of psychophysiological stress responses in fibromyalgia syndrome patients. Arthritis Res Ther. 2006, 8 (1): R9-10.1186/ar1863.CrossRefPubMed Thieme K, Turk D: Heterogeneity of psychophysiological stress responses in fibromyalgia syndrome patients. Arthritis Res Ther. 2006, 8 (1): R9-10.1186/ar1863.CrossRefPubMed
19.
go back to reference de Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S: Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. Rheumatol Int. 2008, 29 (5): 509-515. 10.1007/s00296-008-0722-5.CrossRefPubMed de Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S: Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. Rheumatol Int. 2008, 29 (5): 509-515. 10.1007/s00296-008-0722-5.CrossRefPubMed
20.
go back to reference Häuser W, Akritidou I, Felde E, Klauenberg S, Maier C, Hoffmann A, Köllner V, Hinz A: [Steps towards a symptom-based diagnosis of fibromyalgia syndrome. Symptom profiles of patients from different clinical settings.][German]. Z Rheumatol. 2008, 67: 511-515. 10.1007/s00393-008-0327-0.CrossRefPubMed Häuser W, Akritidou I, Felde E, Klauenberg S, Maier C, Hoffmann A, Köllner V, Hinz A: [Steps towards a symptom-based diagnosis of fibromyalgia syndrome. Symptom profiles of patients from different clinical settings.][German]. Z Rheumatol. 2008, 67: 511-515. 10.1007/s00393-008-0327-0.CrossRefPubMed
21.
go back to reference Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP, Sharma U, Martin SA, Barrett JA, Haig G: A 14-week, randomized, double-blind, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008, 9 (9): 792-805. 10.1016/j.jpain.2008.03.013.CrossRefPubMed Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP, Sharma U, Martin SA, Barrett JA, Haig G: A 14-week, randomized, double-blind, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008, 9 (9): 792-805. 10.1016/j.jpain.2008.03.013.CrossRefPubMed
22.
go back to reference Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA: Patient perspectives on the impact of fibromyalgia. Patient Educ Couns. 2008, 73 (1): 114-120. 10.1016/j.pec.2008.06.005.CrossRefPubMedPubMedCentral Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA: Patient perspectives on the impact of fibromyalgia. Patient Educ Couns. 2008, 73 (1): 114-120. 10.1016/j.pec.2008.06.005.CrossRefPubMedPubMedCentral
23.
go back to reference Miller GA: The magical number seven plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1956, 63 (2): 81-97. 10.1037/h0043158.CrossRefPubMed Miller GA: The magical number seven plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1956, 63 (2): 81-97. 10.1037/h0043158.CrossRefPubMed
24.
go back to reference Streiner DL, Norman GR: Health measurement scales: a practical guide to their development and use. 2003, New York: Oxford University Press, 3 Streiner DL, Norman GR: Health measurement scales: a practical guide to their development and use. 2003, New York: Oxford University Press, 3
25.
go back to reference Kleinbaum DG, Klein M: Logistic Regression. A Self-Learning Text. 2002, New York, NY: Springer-Verlag, 2 Kleinbaum DG, Klein M: Logistic Regression. A Self-Learning Text. 2002, New York, NY: Springer-Verlag, 2
26.
go back to reference Aldenderfer MS, Blashfield RK: Cluster Analysis. 1984, Newbury Park, CA: Sage Publications, IncCrossRef Aldenderfer MS, Blashfield RK: Cluster Analysis. 1984, Newbury Park, CA: Sage Publications, IncCrossRef
27.
go back to reference Davison ML: Multidimensional Scaling. 1983, New York, NY: John Wiley & Sons Davison ML: Multidimensional Scaling. 1983, New York, NY: John Wiley & Sons
28.
go back to reference SAS Institute: SAS/STAT User's Guide. Version 8.2. 2001, Cary, NC: SAS Institute SAS Institute: SAS/STAT User's Guide. Version 8.2. 2001, Cary, NC: SAS Institute
29.
go back to reference Scharf MB, Baumann M, Berkowitz DV: The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol. 2003, 30: 1070-1074.PubMed Scharf MB, Baumann M, Berkowitz DV: The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol. 2003, 30: 1070-1074.PubMed
30.
go back to reference Moldofsky H, Alvarez-Horine S: Effects of sodium oxybate on sleep physiology and sleep-related symptoms in fibromyalgia. [abstract]. Ann Rheum Dis. 2008, 67 (Suppl II): 256- Moldofsky H, Alvarez-Horine S: Effects of sodium oxybate on sleep physiology and sleep-related symptoms in fibromyalgia. [abstract]. Ann Rheum Dis. 2008, 67 (Suppl II): 256-
31.
go back to reference Arnold L, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005, 119: 5-15. 10.1016/j.pain.2005.06.031.CrossRefPubMed Arnold L, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005, 119: 5-15. 10.1016/j.pain.2005.06.031.CrossRefPubMed
32.
go back to reference Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM: Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008, 136 (3): 432-444. 10.1016/j.pain.2008.02.024.CrossRefPubMed Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM: Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008, 136 (3): 432-444. 10.1016/j.pain.2008.02.024.CrossRefPubMed
33.
go back to reference Clauw DJ, Mease P, Palmer RH, Gendreau M, Wang Y: Milnacipran for the treatment of fibromyalgia in adults: a 15-Week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008, 30 (11): 1988-2004. 10.1016/j.clinthera.2008.11.009.CrossRefPubMed Clauw DJ, Mease P, Palmer RH, Gendreau M, Wang Y: Milnacipran for the treatment of fibromyalgia in adults: a 15-Week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008, 30 (11): 1988-2004. 10.1016/j.clinthera.2008.11.009.CrossRefPubMed
34.
go back to reference Russell IJ: Fibromyalgia syndrome: Approach to management. Prim Psychiatry. 2006, 13 (9): 76-84. Russell IJ: Fibromyalgia syndrome: Approach to management. Prim Psychiatry. 2006, 13 (9): 76-84.
35.
go back to reference Serra E: Duloxetine and pregabalin: safe and effective for the long-term treatment of fibromyaliga? [commentary]. Nat Clin Pract Neurol. 2008, 4 (11): 594-595. 10.1038/ncpneuro0936.CrossRefPubMed Serra E: Duloxetine and pregabalin: safe and effective for the long-term treatment of fibromyaliga? [commentary]. Nat Clin Pract Neurol. 2008, 4 (11): 594-595. 10.1038/ncpneuro0936.CrossRefPubMed
36.
go back to reference Mease PJ, Seymour K: Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy?. Curr Pain Headache Rep. 2008, 12 (6): 399-405. 10.1007/s11916-008-0068-4.CrossRefPubMed Mease PJ, Seymour K: Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy?. Curr Pain Headache Rep. 2008, 12 (6): 399-405. 10.1007/s11916-008-0068-4.CrossRefPubMed
37.
go back to reference Affleck G, Urrows S, Tennen H, Higgins P, Abeles M: Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996, 68 (2-3): 363-368. 10.1016/S0304-3959(96)03226-5.CrossRefPubMed Affleck G, Urrows S, Tennen H, Higgins P, Abeles M: Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996, 68 (2-3): 363-368. 10.1016/S0304-3959(96)03226-5.CrossRefPubMed
38.
go back to reference McKracken LM, Iverson GL: Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag. 2002, 7 (2): 75-79.CrossRef McKracken LM, Iverson GL: Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag. 2002, 7 (2): 75-79.CrossRef
39.
go back to reference Smith MT, Haythornthwaite JA: How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev. 2004, 8 (2): 119-132. 10.1016/S1087-0792(03)00044-3.CrossRefPubMed Smith MT, Haythornthwaite JA: How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev. 2004, 8 (2): 119-132. 10.1016/S1087-0792(03)00044-3.CrossRefPubMed
40.
go back to reference Moldofsky H, Scarisbrick P, England R, Smythe H: Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med. 1975, 37 (4): 341-351.CrossRefPubMed Moldofsky H, Scarisbrick P, England R, Smythe H: Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med. 1975, 37 (4): 341-351.CrossRefPubMed
41.
go back to reference Bigatti SM, Hernandez AM, Cronan TA, Rand KL: Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression. Arthritis Rheum. 2008, 59 (7): 961-967. 10.1002/art.23828.CrossRefPubMedPubMedCentral Bigatti SM, Hernandez AM, Cronan TA, Rand KL: Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression. Arthritis Rheum. 2008, 59 (7): 961-967. 10.1002/art.23828.CrossRefPubMedPubMedCentral
42.
go back to reference Burns JW, Crofford LJ, Chervin RD: Sleep stage dynamics in fibromyalgia patients and controls. Sleep Med. 2008, 9 (6): 689-696. 10.1016/j.sleep.2007.10.022.CrossRefPubMed Burns JW, Crofford LJ, Chervin RD: Sleep stage dynamics in fibromyalgia patients and controls. Sleep Med. 2008, 9 (6): 689-696. 10.1016/j.sleep.2007.10.022.CrossRefPubMed
43.
go back to reference Katz RS, Heard AR, Mills M, Leavitt F: The Prevalence and Clinical Impact of Reported Cognitive Difficulties (Fibrofog) in Patients With Rheumatic Disease With and Without Fibromyalgia. J Clin Rheumatol. 2004, 10 (2): 53-58. 10.1097/01.rhu.0000120895.20623.9f.CrossRefPubMed Katz RS, Heard AR, Mills M, Leavitt F: The Prevalence and Clinical Impact of Reported Cognitive Difficulties (Fibrofog) in Patients With Rheumatic Disease With and Without Fibromyalgia. J Clin Rheumatol. 2004, 10 (2): 53-58. 10.1097/01.rhu.0000120895.20623.9f.CrossRefPubMed
44.
go back to reference Rutledge DN, Mouttapa M, Wood PB: Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation. Nurs Res. 2009, 58 (5): 359-367. 10.1097/NNR.0b013e3181b499d2.CrossRefPubMed Rutledge DN, Mouttapa M, Wood PB: Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation. Nurs Res. 2009, 58 (5): 359-367. 10.1097/NNR.0b013e3181b499d2.CrossRefPubMed
45.
go back to reference Harris RE, Williams DA, McLean SA, Sen A, Hufford M, Gendreau RM, Gracely RH, Clauw DJ: Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 2005, 52 (11): 3670-3674. 10.1002/art.21407.CrossRefPubMed Harris RE, Williams DA, McLean SA, Sen A, Hufford M, Gendreau RM, Gracely RH, Clauw DJ: Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 2005, 52 (11): 3670-3674. 10.1002/art.21407.CrossRefPubMed
46.
go back to reference Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT: Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry. 1991, 148 (12): 1721-1726.CrossRefPubMed Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT: Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry. 1991, 148 (12): 1721-1726.CrossRefPubMed
47.
go back to reference Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Identifying the clinical domains of fibromyalgia: Contributions from clinician and patient delphi exercises. Arthritis Rheum. 2008, 59 (7): 952-960. 10.1002/art.23826.CrossRefPubMed Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Identifying the clinical domains of fibromyalgia: Contributions from clinician and patient delphi exercises. Arthritis Rheum. 2008, 59 (7): 952-960. 10.1002/art.23826.CrossRefPubMed
48.
go back to reference Markkula R, Järvinen P, Leino-Arjas P, Koskenvuo M, Kalso E, Kaprio J: Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain. 2008, 13 (7): 744-750. 10.1016/j.ejpain.2008.09.007.CrossRefPubMed Markkula R, Järvinen P, Leino-Arjas P, Koskenvuo M, Kalso E, Kaprio J: Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain. 2008, 13 (7): 744-750. 10.1016/j.ejpain.2008.09.007.CrossRefPubMed
49.
go back to reference Mease PJ, Choy EH: Pharmacotherapy of fibromyalgia. Rheum Dis Clin North Am. 2009, 35 (2): 359-372. 10.1016/j.rdc.2009.06.007.CrossRefPubMed Mease PJ, Choy EH: Pharmacotherapy of fibromyalgia. Rheum Dis Clin North Am. 2009, 35 (2): 359-372. 10.1016/j.rdc.2009.06.007.CrossRefPubMed
50.
go back to reference Wilson HD, Robinson JP, Turk D: Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Rheum. 2009, 61 (4): 527-534. 10.1002/art.24163.CrossRefPubMedPubMedCentral Wilson HD, Robinson JP, Turk D: Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Rheum. 2009, 61 (4): 527-534. 10.1002/art.24163.CrossRefPubMedPubMedCentral
Metadata
Title
Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
Authors
Robert M Bennett
Jon Russell
Joseph C Cappelleri
Andrew G Bushmakin
Gergana Zlateva
Alesia Sadosky
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2010
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-11-134

Other articles of this Issue 1/2010

BMC Musculoskeletal Disorders 1/2010 Go to the issue